Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.08.04.742914

Structural basis for monobody OP-4 binding to open-form adenylate kinase

Abstract

Monobodies are fibronectin type-III-based binding proteins that specifically bind target proteins and regulate their functions. We previously identified monobodies that selectively recognize either the OPEN or CLOSED conformation of adenylate kinase (Adk), revealing that monobodies can discriminate distinct conformational states of a target protein. However, the molecular basis of OPEN-form recognition has remained unclear because the structure of the complex between an OPEN-form-specific monobody and Adk had not been determined. To address this issue, we determined the crystal structure of the complex between Adk and the OPEN-form-specific monobody OP-4, employing hierarchical clustering analysis of X-ray diffraction datasets. The structure revealed that OP-4 binds to the surface formed by the expanded LID and CORE domains of Adk. Mutations in the interface residues reduced the OP- 4-binding affinity, indicating that the crystallographically identified interface is also relevant in solution. In particular, R123 mutations markedly impaired OP-4 binding. Molecular dynamics simulations further suggested that the R123-D159-R156 hydrogen-bond network is retained in solution and may contribute to efficient complex formation. These findings establish the structural basis for monobody OP-4 binding to open-form Adk and identify the R123-centered interaction network as a key determinant of complex formation. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=153 SRC="FIGDIR/small/742914v1_ufig1.gif" ALT="Figure 1"> View larger version (46K): org.highwire.dtl.DTLVardef@67570forg.highwire.dtl.DTLVardef@84b9caorg.highwire.dtl.DTLVardef@1c1b782org.highwire.dtl.DTLVardef@f6ed05_HPS_FORMAT_FIGEXP M_FIG C_FIG HighlightsO_LIThe crystal structure of the OPEN-form adenylate kinase/monobody OP-4 complex was successfully determined. C_LIO_LIThe crystal structure revealed that OP-4 binds to surface formed by the expanded LID and CORE domains in adenylate kinase. C_LIO_LIIsothermal titration calorimetry measurements for adenylate kinase mutants confirmed that the binding modes observed in solution are consistent with those observed in the crystal structure. C_LIO_LIMolecular dynamics simulations suggested that the R123-D159-R156 hydrogen bond network prior to OP-4 binding is important for complex formation. C_LI

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Orito, N., Nakamura, I., Yoshihara, K., Onishi, K., Toma-Fukai, S., Matsuura, H., Tanaka, S.-i., Matsuo, T.. 2026-08-05. Structural basis for monobody OP-4 binding to open-form adenylate kinase. https://doi.org/10.64898/2026.08.04.742914

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Deep reinforcement learning-driven discovery of a MsbA-targeted small-molecule antibiotic for the treatment of Acinetobacter baumannii infection

Antibiotics with new mechanisms are highly pursued to address the threat of infections caused by drug-resistant Gram-negative bacteria. Targeting MsbA, a key protein of the lipopolysaccharide biosynthesis pathway, represents a promising strategy to discover new classes of antibiotics. However, currently available MsbA-targeted molecules either lack sufficient potency or have unfavorable properties, necessitating expansion of chemical space. In this study, we chose the most promising cerastecin Cpd 4 as the template, and used two Artificial Intelligence (AI)-based tools, i.e. Link-INVENT and AutoMolDesigner for molecular design, performed chemical derivatization and antibacterial activity evaluation, which led to the discovery of Y-11 (MIC for A. baumannii: 0.5 g/mL). Encouragingly, Y-11 showed equivalent potency to Cpd4 for carbapenem-resistant A. baumannii, and less cytotoxicity and hemolysis as well as lower spontaneous resistance frequency. In vivo efficacy study demonstrated that Y-11 could effectively reduce bacterial loads in the mice infected by A. baumannii. The following mechanism study including molecular dynamics simulation, biochemical assay, and transmission electron microscope (TEM) analysis suggested that Y-11 inhibited the transport of lipooligosaccharide and impaired the formation of outer membrane, probably by competitively binding to the substrate binding site of MsbA and modulating ATPase activity. Taken together, we have discovered a MsbA-targeted small molecule Y-11 via AI-driven drug design, which provides a foundation for future antibiotic development.

biochemistry↗

Dynamic architecture of the Rixosome reveals mechanism of activation and ITS2 processing

Eukaryotic ribosome assembly requires the coordinated processing and extensive remodeling of pre-rRNAs. During late nuclear maturation of the 60S subunit, sequential removal of the internal transcribed spacer 2 (ITS2) is initiated by endonucleolytic cleavage at site C2 by the conserved Las1 nuclease. Las1 acts together with the kinase Grc3 and the Rix1 complex to form the Rixosome, which also functions in transcriptional regulation. However, the assembly of the Rixosome, its recruitment to pre-ribosomes, and its activation for ITS2 cleavage remain unclear. Here, we present cryo-EM structures of the human LAS1 complex, two structures of the isolated Rixosome and nine transition states of Rix1-bound pre-60S particles from Schizosaccharomyces pombe. These structures reveal a dynamic Rixosome architecture in which the heterotetrameric Las1 complex engages one or two copies of the Rix1 complex. Rix1 binding is highly flexible in the human Rixosome but rigid in the yeast complex. The isolated yeast Rixosome remains inactive, but binding to the pre-60S particle triggers a structural rearrangement that allows for substrate engagement and activation of the nuclease. Together, our results define the dynamic architecture of the Rixosome and provide a structural framework for ITS2 processing during nuclear maturation of the eukaryotic 60S ribosomal subunit.

biochemistry↗

SGFP-Grid Split GFP Graphene Grids

Affinity graphene grids provide a promising approach for selective protein capture in cryo-EM. Here, we introduce a split-GFP graphene grid platform(SGFP-G), in which graphene-conjugated GFP 1-10 selectively captures GFP11 tagged proteins from low concentration samples or cell lysates. This platform enables rapid assessment of target protein enrichment and particle distribution before vitrification via fluorescence imaging, while the grid design positions captured proteins away from the graphene surface and air-water interface. We also introduce a unique strategy to minimize nonspecific protein adsorption, thereby improving the selective enrichment of target proteins on this grid. Using GFP11-tagged apoferritin, we demonstrate fluorescence guided protein capture and obtain a 2.58 [A] cryoEM reconstruction, establishing SGFP-G as an affinity grid platform for high resolution structural studies with reduced sample requirements.

biochemistry↗